Immunoassay News and Research

RSS

New paper-based test for early Lyme diagnosis

A new paper in the journal ACS Nano reports the development of an incredibly cheap and highly sensitive test to diagnose Lyme disease in its earliest stages, when it can be most easily, effectively and inexpensively treated.

18 Dec 2019

Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform

Tecan unveiled its new Cavro Magni Flex OEM robotic liquid handling instrument development platform at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo.

From Tecan 6 Dec 2019

ADDF announces new awards through its Diagnostics Accelerator initiative

The Alzheimer's Drug Discovery Foundation announced six new investments totaling $6 million through its Diagnostics Accelerator initiative.

4 Dec 2019

Lyme vaccine on the horizon, says new study

Lyme disease is a dreaded disease caused by the bite of an infected tick. The only way to prevent it is by not getting bitten by the tick. However, this is not a practical recommendation, since even today about 300,000 thousand people are diagnosed with this infection, in the US alone, and over 100,000 in Europe, each year.

17 Oct 2019

New microfluidic test can detect Lyme disease within 15 minutes

Some 300,000 people in the U.S. are diagnosed with Lyme disease every year. Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, the disease if left untreated can cause serious neurologic, cardiac, and/or rheumatologic complications.

11 Oct 2019

Quanterix corporation releases operating results for second quarter 2019

Quanterix announced financial results for the three and six months ended June 30, 2019.

From Quanterix 6 Aug 2019

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease.

30 Jul 2019

Web Industries highlights new capabilities and services for LFI, medical diagnostic devices at AACC 2019

Medical device OEMs in search of new solutions for lateral flow immunoassay and medical diagnostic devices will discover novel technologies at AACC 2019.

27 Jul 2019

Eisai presents new research evaluating correlation of Abeta in plasma and CSF with automated protein assay system

Eisai Co.,Ltd. announced its latest research on evaluation about correlation of amyloid beta (Abeta) in plasma and in cerebrospinal fluid (CSF) by high precision measurement with the newly developed automated protein assay system, jointly developed with Sysmex Corporation, using full automated immunoassay system HISCLTM series for creating the simplified diagnosis of Alzheimer's disease with blood was presented at the Alzheimer's Association International Conference held in Los Angeles, California, United States, from July 14 to 18, 2019.

From Eisai 19 Jul 2019

Quanterix to convene leading industry researchers at Alzheimer’s Association International Conference 2019 following closing of UmanDiagnostics acquisition

Quanterix marks major milestones as it continues to expand its footprint in neurology and lead the digital biomarker revolution across healthcare.

From Quanterix 11 Jul 2019

Expedeon AG launches Lightning-Link Metal Labeling Kits to support single cell analysis

Expedeon AG announced today it has introduced Lightning-Link Metal Labeling Kits for use in multiple immunoassay-based applications to support single cell analysis.

24 Jun 2019

Quanterix raises $49.7 million and announces introduction of latest model Simoa HD-X Analyzer at Bio 2019 International Convention

Quanterix, announced that it issued approximately 2.2 million shares of common stock last week, raising $49.7 million in gross proceeds.

From Quanterix 4 Jun 2019

New diagnostic tool helps develop improved RDTs and support public health surveillance

PATH and Quansys Biosciences, Inc. have announced the launch of a new diagnostic tool designed to help researchers develop more sensitive and reliable malaria rapid diagnostic tests and to support public health surveillance.

31 May 2019

Expedeon announces addition of CaptSure DIY ELISA to immunoassay product portfolio

CaptSure DIY ELISA will complement Expedeon AG’s product offering, as the Company announced today. The technology was developed by TGR BioSciences, which was acquired by Expedeon in May 2018.

29 May 2019

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

20 Mar 2019

Fingermark imaging for identification of drugs

In a paper to be published in the forthcoming issue in NANO, researchers from Zhejiang have uncovered a novel method of using nanocarrier-based biological fluorescent probes for detecting amphetamine and ketamine in latent fingermark, in a bid to combat drug abuse.

15 Mar 2019

Scientists develop GC-MS vitamin D test that costs as little as $0.70

Scientists have developed a rapid, sensitive and cheap test for vitamin D3 levels in blood for clinical assessment, with complete analysis costing $0.70 per sample.

11 Mar 2019

Quanterix corporation releases operating results for fourth quarter and full year 2018

Quanterix announced financial results for the three months and twelve months ended Dec. 31, 2018.

From Quanterix 7 Mar 2019

Expedeon signs license agreement for use of Lightning-Link technology

Expedeon AG, today announced it has signed a supply and license agreement with Cell Guidance Systems for use of Expedeon’s proprietary Lightning-Link Rapid Biotin..

9 Jan 2019

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel's Sofia 2 Lyme+ FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi, Borrelia garinii, and Borrelia afzelii from serum and plasma specimens.

19 Dec 2018